Page last updated: 2024-08-23

fludarabine phosphate and Blood Diseases

fludarabine phosphate has been researched along with Blood Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabanillas, F; Dimopoulos, M; Estey, E; Gandhi, V; Kantarjian, H; Keating, MJ; Kemena, A; O'Brien, S; Plunkett, W; Robertson, LE1
Balcerzak, SP; Benedetti, J; Dakhil, SR; Grever, MR; Miller, TP; Taylor, SA1
Cabanillas, F; Dimopoulos, M; Gandhi, V; Gregoire, V; Kantarjian, H; Keating, MJ; McLaughlin, P; O'Brien, S; Robertson, LE; Yang, LY1
Alberts, DS; Green, S; Miller, TP; Stephens, RL; Stock-Novack, DL; Surwit, EA; Von Hoff, DD1
Carpenter, JT; Raney, M; Vogel, CL; Wang, G1

Reviews

2 review(s) available for fludarabine phosphate and Blood Diseases

ArticleYear
Fludarabine phosphate: a new active agent in hematologic malignancies.
    Seminars in hematology, 1994, Volume: 31, Issue:1

    Topics: Animals; Clinical Trials as Topic; Hematologic Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Vidarabine Phosphate; Waldenstrom Macroglobulinemia

1994
New initiatives with fludarabine monophosphate in hematologic malignancies.
    Seminars in oncology, 1993, Volume: 20, Issue:5 Suppl 7

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Hematologic Diseases; Humans; Neoplasms; Remission Induction; Vidarabine Phosphate

1993

Trials

3 trial(s) available for fludarabine phosphate and Blood Diseases

ArticleYear
A Southwest Oncology Group phase II evaluation of fluderabine monophosphate in sarcoma.
    Investigational new drugs, 1994, Volume: 12, Issue:3

    Topics: Antimetabolites, Antineoplastic; Hematologic Diseases; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Sarcoma; Sleep Stages; Vidarabine Phosphate

1994
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced endometrial cancer. A Southwest Oncology Group Study.
    American journal of clinical oncology, 1991, Volume: 14, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Evaluation; Female; Hematologic Diseases; Humans; Middle Aged; Uterine Neoplasms; Vidarabine Phosphate

1991
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trial.
    Cancer treatment reports, 1986, Volume: 70, Issue:10

    Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Clinical Trials as Topic; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Middle Aged; Neoplasm Metastasis; Vidarabine Phosphate

1986